SCB-518

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSCB-518
Drug Alias NameSCB-518
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionApolipoprotein A-I modulators
TargetsApolipoprotein A-I
Therapy Area/IndicationsHeart Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesClover Biopharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHeart Diseases

Other Information

ATC CodeN/A
Related LinksN/A